Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $98.14

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have received an average recommendation of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation […]

Leave a Reply

Your email address will not be published.

Previous post LiqTech International (NASDAQ:LIQT) vs. ZOOZ Power (NASDAQ:ZOOZ) Head to Head Contrast
Next post Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $22.20 Average Price Target from Analysts